Greenwich LifeSciences GLSI
NASDAQ GLSI
$15.84 +0.21 (+1.34%)
As of: Sep 4, 2026 · 3:55 PM EDT

Greenwich LifeSciences (GLSI) Goodwill & Intangibles (2019 - 2025)

Greenwich LifeSciences' (GLSI) quarterly Goodwill & Intangibles came in at $876.0 in Q1 2025, down 80.48% YoY from $4488.0 in Q1 2024, and down 50.76% on a QoQ basis from $1779.0 in Q4 2024.

Analysis

Greenwich LifeSciences (GLSI) Goodwill & Intangibles (2019 - 2025) Analysis & Trends

Greenwich LifeSciences (GLSI) has 7 years of Goodwill & Intangibles data on file, last reported at $876.0 in Q1 2025.

  • Quarterly Goodwill & Intangibles fell 80.48% year-over-year to $876.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $876.0 (down 80.48% YoY) and the FY2024 annual result came in at $1779.0, down 67.0% from the prior year.
  • Goodwill & Intangibles slipped to $876.0 in Q1 2025, from $1779.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $15324.0 in Q1 2021 to a low of $876.0 in Q1 2025.
  • A 5-year average of $8100.0 and a median of $8100.0 in 2023 frame the typical range for Goodwill & Intangibles.
  • Annual changes were most pronounced in 2021 — Goodwill & Intangibles declined 21.09% — and 2025, when it plunged 80.48%.
  • Tracing GLSI's Goodwill & Intangibles over 5 years: stood at $12615.0 in 2021, then retreated by 28.63% to $9003.0 in 2022, then tumbled by 40.12% to $5391.0 in 2023, then slumped by 67.0% to $1779.0 in 2024, then sank by 50.76% to $876.0 in 2025.
  • The last three Goodwill & Intangibles figures came in at $876.0 (Q1 2025), $1779.0 (Q4 2024), and $2682.0 (Q3 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Greenwich LifeSciences 231.59 Mn 231.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 876.00
Dec 31, 2024 1,779.00
Sep 30, 2024 2,682.00
Jun 30, 2024 3,585.00
Mar 31, 2024 4,488.00
Dec 31, 2023 5,391.00
Sep 30, 2023 6,294.00
Jun 30, 2023 7,197.00
Mar 31, 2023 8,100.00
Dec 31, 2022 9,003.00
Sep 30, 2022 9,906.00
Jun 30, 2022 10,809.00
Mar 31, 2022 11,712.00
Dec 31, 2021 12,615.00
Sep 30, 2021 13,518.00
Jun 30, 2021 14,421.00
Mar 31, 2021 15,324.00
Dec 31, 2020 16,227.00
Sep 30, 2020 17,130.00
Dec 31, 2019 19,836.00